These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23595360)

  • 1. Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing.
    Roth WJ; Kissinger CB; McCain RR; Cooper BR; Marchant-Forde JN; Vreeman RC; Hannou S; Knipp GT
    AAPS J; 2013 Jul; 15(3):763-74. PubMed ID: 23595360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast mouse PK (Fast PK): a rapid screening method to increase pharmacokinetic throughput in pre-clinical drug discovery.
    Reddy J; Madishetti S; Vachaspati PR
    Eur J Pharm Sci; 2012 Sep; 47(2):444-50. PubMed ID: 22789493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review.
    Henze LJ; Koehl NJ; O'Shea JP; Kostewicz ES; Holm R; Griffin BT
    J Pharm Pharmacol; 2019 Apr; 71(4):581-602. PubMed ID: 29635685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A smart approach to enable preclinical studies in pharmaceutical industry: PLGA-based extended release formulation platform for subcutaneous applications.
    Strack P; Külzer R; Sommer F; Bretschneider T; Merkel OM; Grube A
    Drug Dev Ind Pharm; 2020 Apr; 46(4):635-645. PubMed ID: 32163304
    [No Abstract]   [Full Text] [Related]  

  • 5. Preclinical dose number and its application in understanding drug absorption risk and formulation design for preclinical species.
    Wuelfing WP; Daublain P; Kesisoglou F; Templeton A; McGregor C
    Mol Pharm; 2015 Apr; 12(4):1031-9. PubMed ID: 25671350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection model.
    Lyons MA; Lenaerts AJ
    J Pharmacokinet Pharmacodyn; 2015 Aug; 42(4):375-89. PubMed ID: 26026426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M; Nick S; Parrott N; Röthlisberger D
    Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary pharmacokinetic study of repeated doses of rifampin and rifapentine in guinea pigs.
    Dutta NK; Alsultan A; Peloquin CA; Karakousis PC
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1535-7. PubMed ID: 23295923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential Use of Piglets as Human Pediatric Surrogate for Preclinical Pharmacokinetic and Pharmacodynamic Drug Testing.
    Gasthuys E; Vandecasteele T; De Bruyne P; Walle JV; De Backer P; Cornillie P; Devreese M; Croubels S
    Curr Pharm Des; 2016; 22(26):4069-85. PubMed ID: 26935702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Rifampin-Mediated OATP1B1 and OATP1B3 Transporter Inhibition on the Pharmacokinetics of the P2Y12 Receptor Antagonist Selatogrel.
    Schilling U; Dingemanse J; Voors-Pette C; Romeijn C; Dogterom P; Ufer M
    Clin Transl Sci; 2020 Sep; 13(5):886-890. PubMed ID: 32166864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyzing the Potential Root Causes of Variability of Pharmacokinetics in Preclinical Species.
    Daublain P; Feng KI; Altman MD; Martin I; Mukherjee S; Nofsinger R; Northrup AB; Tschirret-Guth R; Cartwright M; McGregor C
    Mol Pharm; 2017 May; 14(5):1634-1645. PubMed ID: 28329443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of capillary microsampling for rat pharmacokinetic studies: Comparison of tail-vein bleed to jugular vein cannula sampling.
    Korfmacher W; Luo Y; Ho S; Sun W; Shen L; Wang J; Wu Z; Guo Y; Snow G; O'Shea T
    J Pharmacol Toxicol Methods; 2015; 76():7-14. PubMed ID: 26164093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis.
    Stott KE; Pertinez H; Sturkenboom MGG; Boeree MJ; Aarnoutse R; Ramachandran G; Requena-Méndez A; Peloquin C; Koegelenberg CFN; Alffenaar JWC; Ruslami R; Tostmann A; Swaminathan S; McIlleron H; Davies G
    J Antimicrob Chemother; 2018 Sep; 73(9):2305-2313. PubMed ID: 29701775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative prediction of human pharmacokinetics and pharmacodynamics of imigliptin, a novel DPP-4 inhibitor, using allometric scaling, IVIVE and PK/PD modeling methods.
    Liu D; Ma X; Liu Y; Zhou H; Shi C; Wu F; Jiang J; Hu P
    Eur J Pharm Sci; 2016 Jun; 89():73-82. PubMed ID: 27108678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
    Wu Y; Loper A; Landis E; Hettrick L; Novak L; Lynn K; Chen C; Thompson K; Higgins R; Batra U; Shelukar S; Kwei G; Storey D
    Int J Pharm; 2004 Nov; 285(1-2):135-46. PubMed ID: 15488686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the site of blood sampling on pharmacokinetic parameters following sublingual dosing to dogs.
    Sohlberg E; Halldin MM; Annas A; Königsson K; Jansson B; Pehrson R; Borg N
    J Pharmacol Toxicol Methods; 2013; 67(1):1-4. PubMed ID: 23138149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploratory population pharmacokinetics (e-PPK) analysis for predicting human PK using exploratory ADME data during early drug discovery research.
    Tabata K; Hamakawa N; Sanoh S; Terashita S; Teramura T
    Eur J Drug Metab Pharmacokinet; 2009; 34(2):117-28. PubMed ID: 19645221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of a single oral dose of grapiprant in juvenile pigs (Sus scrofa domestica).
    Kleine S; Hampton CE; Smith C; Bussieres G; Mulon PY; Seddighi R; Cox S; Smith J
    J Vet Pharmacol Ther; 2023 Sep; 46(5):269-275. PubMed ID: 37493273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi.
    van Oosterhout JJ; Dzinjalamala FK; Dimba A; Waterhouse D; Davies G; Zijlstra EE; Molyneux ME; Molyneux EM; Ward S
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6175-80. PubMed ID: 26248378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.